Early trial tests promising drug cocktail for Tough-to-Treat blood cancer

NCT ID NCT04108195

Ongoing Disease control Sponsor: Janssen Research & Development, LLC Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing several combinations of new and existing drugs for people with multiple myeloma that has returned or stopped responding to standard treatments. The main goals are to find safe dose levels and check for early signs that the treatments work. The study involves about 290 participants and will last about five and a half years.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Arthur J E Child Comprehensive Cancer Centre

Calgary, Alberta, T2N 5G2, Canada
City of Hope National Medical Center

Duarte, California, 91010, United States
City of Hope Orange County Lennar Foundation Cancer Center

Irvine, California, 92618, United States
Clinica Univ. de Navarra

Pamplona, 31008, Spain
Germans Trias I Pujol

Barcelona, 08916, Spain
Hosp Clinic de Barcelona

Barcelona, 08036, Spain
Hosp Clinico Univ de Salamanca

Salamanca, 37007, Spain
Hosp Univ Fund Jimenez Diaz

Madrid, 28040, Spain
Inst. Cat. Doncologia-H Duran I Reynals

Barcelona, 08908, Spain
LUMC

Leiden, 2333ZA, Netherlands
Levine Cancer Institute

Charlotte, North Carolina, 28204, United States
Medical College Of Wisconsin

Milwaukee, Wisconsin, 53226, United States
Mount Sinai Medical Center

New York, New York, 10029, United States
The Blavatnik Family Chelsea Medical Center at Mount Sinai

New York, New York, 10011, United States
Universitaetsklinikum Hamburg Eppendorf

Hamburg, 20246, Germany
Universitaetsklinikum Heidelberg

Heidelberg, 69120, Germany
Universitatsklinikum Freiburg

Freiburg im Breisgau, 79106, Germany
Universitatsklinikum Wurzburg

Würzburg, 97080, Germany
University Health Network UHN Princess Margaret Cancer Centre

Toronto, Ontario, M5G 2M9, Canada
University of California San Francisco

San Francisco, California, 94143, United States
University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States
VU Medisch Centrum

Amsterdam, 1081 HV, Netherlands
Vanderbilt Ingram Cancer Center

Nashville, Tennessee, 37232, United States
Wake Forest Baptist Medical Center

Winston-Salem, North Carolina, 27157, United States

Conditions

Explore the condition pages connected to this study.

MULTIPLE MYELOMA